Page last updated: 2024-08-26

artenimol and Liver Diseases, Alcoholic

artenimol has been researched along with Liver Diseases, Alcoholic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, M; Chen, A; Chen, X; Jin, H; Kai, J; Lu, C; Shao, J; Yao, Z; Zhang, C; Zhang, F; Zheng, S1
Lu, C; Shao, J; Xu, W; Yao, L; Zhang, F; Zheng, S1

Other Studies

2 other study(ies) available for artenimol and Liver Diseases, Alcoholic

ArticleYear
Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

    Topics: Animals; Apoptosis; Artemisinins; Chromones; Endoplasmic Reticulum Stress; Ethanol; Hepatocytes; Lipid Metabolism; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred ICR; Mitochondria; Morpholines; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction

2018
Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
    Toxicology and applied pharmacology, 2017, Jan-15, Volume: 315

    Topics: Animals; Artemisinins; Fatty Liver, Alcoholic; Liver Diseases, Alcoholic; Male; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear

2017